303 related articles for article (PubMed ID: 18198943)
1. Conformational equilibria in monomeric alpha-synuclein at the single-molecule level.
Sandal M; Valle F; Tessari I; Mammi S; Bergantino E; Musiani F; Brucale M; Bubacco L; Samorì B
PLoS Biol; 2008 Jan; 6(1):e6. PubMed ID: 18198943
[TBL] [Abstract][Full Text] [Related]
2. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
Jiang C; Chang JY
Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers.
Brucale M; Sandal M; Di Maio S; Rampioni A; Tessari I; Tosatto L; Bisaglia M; Bubacco L; Samorì B
Chembiochem; 2009 Jan; 10(1):176-83. PubMed ID: 19067456
[TBL] [Abstract][Full Text] [Related]
4. Distinct Mechanisms Determine α-Synuclein Fibril Morphology during Growth and Maturation.
Sidhu A; Segers-Nolten I; Raussens V; Claessens MM; Subramaniam V
ACS Chem Neurosci; 2017 Mar; 8(3):538-547. PubMed ID: 28292187
[TBL] [Abstract][Full Text] [Related]
5. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
Coskuner O; Wise-Scira O
ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
[TBL] [Abstract][Full Text] [Related]
6. Fibril breaking accelerates α-synuclein fibrillization.
Shvadchak VV; Claessens MM; Subramaniam V
J Phys Chem B; 2015 Feb; 119(5):1912-8. PubMed ID: 25582977
[TBL] [Abstract][Full Text] [Related]
7. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
Hayden EY; Kaur P; Williams TL; Matsui H; Yeh SR; Rousseau DL
Biochemistry; 2015 Aug; 54(30):4599-610. PubMed ID: 26161848
[TBL] [Abstract][Full Text] [Related]
8. Intracellular soluble α-synuclein oligomers reduce pyramidal cell excitability.
Kaufmann TJ; Harrison PM; Richardson MJ; Pinheiro TJ; Wall MJ
J Physiol; 2016 May; 594(10):2751-72. PubMed ID: 26915902
[TBL] [Abstract][Full Text] [Related]
9. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
Fredenburg RA; Rospigliosi C; Meray RK; Kessler JC; Lashuel HA; Eliezer D; Lansbury PT
Biochemistry; 2007 Jun; 46(24):7107-18. PubMed ID: 17530780
[TBL] [Abstract][Full Text] [Related]
10. The role of the C-terminus of human α-synuclein: intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers.
Hong DP; Xiong W; Chang JY; Jiang C
FEBS Lett; 2011 Feb; 585(3):561-6. PubMed ID: 21237164
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role.
Emanuele M; Chieregatti E
Biomolecules; 2015 May; 5(2):865-92. PubMed ID: 25985082
[TBL] [Abstract][Full Text] [Related]
12. Oligomers of α-synuclein: picking the culprit in the line-up.
Lorenzen N; Otzen DE
Essays Biochem; 2014; 56():137-48. PubMed ID: 25131592
[TBL] [Abstract][Full Text] [Related]
13. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
14. Dynamical Behavior of Human α-Synuclein Studied by Quasielastic Neutron Scattering.
Fujiwara S; Araki K; Matsuo T; Yagi H; Yamada T; Shibata K; Mochizuki H
PLoS One; 2016; 11(4):e0151447. PubMed ID: 27097022
[TBL] [Abstract][Full Text] [Related]
15. Exploring the accessible conformations of N-terminal acetylated α-synuclein.
Moriarty GM; Janowska MK; Kang L; Baum J
FEBS Lett; 2013 Apr; 587(8):1128-38. PubMed ID: 23499431
[TBL] [Abstract][Full Text] [Related]
16. Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.
Tóth G; Neumann T; Berthet A; Masliah E; Spencer B; Tao J; Jobling MF; Gardai SJ; Bertoncini CW; Cremades N; Bova M; Ballaron S; Chen XH; Mao W; Nguyen P; Tabios MC; Tambe MA; Rochet JC; Junker HD; Schwizer D; Sekul R; Ott I; Anderson JP; Szoke B; Hoffman W; Christodoulou J; Yednock T; Agard DA; Schenk D; McConlogue L
Sci Rep; 2019 Nov; 9(1):16947. PubMed ID: 31740740
[TBL] [Abstract][Full Text] [Related]
17. The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process.
Lee D; Park CW; Paik SR; Choi KY
Biochim Biophys Acta; 2009 Mar; 1794(3):421-30. PubMed ID: 19103312
[TBL] [Abstract][Full Text] [Related]
18. Protein interactions and misfolding analyzed by AFM force spectroscopy.
McAllister C; Karymov MA; Kawano Y; Lushnikov AY; Mikheikin A; Uversky VN; Lyubchenko YL
J Mol Biol; 2005 Dec; 354(5):1028-42. PubMed ID: 16290901
[TBL] [Abstract][Full Text] [Related]
19. Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.
Chang CC; Li HH; Chang YT; Ho YJ; Hsieh LJ; Chiu PY; Cheng YS; Lin CL; Lai TJ
CNS Neurosci Ther; 2018 Jan; 24(1):47-57. PubMed ID: 29092095
[TBL] [Abstract][Full Text] [Related]
20. Structures of the E46K mutant-type α-synuclein protein and impact of E46K mutation on the structures of the wild-type α-synuclein protein.
Wise-Scira O; Dunn A; Aloglu AK; Sakallioglu IT; Coskuner O
ACS Chem Neurosci; 2013 Mar; 4(3):498-508. PubMed ID: 23374074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
